BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.660
+0.040 (2.47%)
At close: Oct 8, 2025, 4:00 PM EDT
1.710
+0.050 (3.01%)
After-hours: Oct 8, 2025, 6:14 PM EDT
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$55,018
Profits / Employee
-$974,875
Market Cap
13.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11 | 0 | - |
| Dec 31, 2023 | 11 | 1 | 10.00% |
| Dec 31, 2022 | 10 | 3 | 42.86% |
| Dec 31, 2021 | 7 | 2 | 40.00% |
| Dec 31, 2020 | 5 | -1 | -16.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BRTX News
- 1 day ago - BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show” - GlobeNewsWire
- 2 days ago - BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market - GlobeNewsWire
- 2 months ago - BioRestorative Therapies, Inc. (BRTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025 - GlobeNewsWire
- 4 months ago - BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates - GlobeNewsWire
- 4 months ago - BioRestorative Announces Share Repurchase Program - GlobeNewsWire
- 4 months ago - BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease - GlobeNewsWire
- 4 months ago - BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025 - GlobeNewsWire